Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study

Autor:	Kwak, Larry W., Sancho, Juan-Manuel, Cho, Seok-Goo, Nakazawa, Hideyuki, Suzumiya, Junji, Tumyan, Gayane, Kim, Jin Seok, Menne, Tobias, Mariz, José, Ilyin, Nikolai, Jurczak, Wojciech, Lopez Martinez, Aurelio, Samoilova, Olga, Zhavrid, Edvard, Yañez Ruiz, Eduardo, Trneny, Marek, Popplewell, Leslie, Ogura, Michinori, Kim, Won-Seog, Lee, Sang Joon, Kim, Sung Hyun, Ahn, Keum Young, Buske, Christian
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia February 2022 22(2):89-97
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect